Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
QSHY granules is a Traditional Chinese Medicine (TCM) herbal formulation developed by Shuguang Hospital, affiliated with the Shanghai University of Traditional Chinese Medicine. It is primarily indicated for the treatment of hyperlipidemia, specifically targeting the phlegm and blood stasis syndrome (TCM pattern). The formula is designed to clear dampness, resolve phlegm, and activate blood circulation to remove stasis, thereby improving lipid profiles. It has been evaluated in prospective, randomized, controlled clinical trials in China to assess its efficacy and safety in reducing serum cholesterol and triglyceride levels in adult patients compared to simulated granules.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on QSHY granules.